Flushing Free Synagogue Temple, listed on the National Register of Historic Places
Chief COVID-19 Officer speaks on day 1,668 of the pandemic
Long COVID-19 Art Plan, Disabled Evacuation, Happy New Year
This week’s journal comes out on Sunday, day 1,670 of the pandemic, and since Thursday night marks the beginning of Rosh Hashanah, Rosch ha-Schana in my native tongue, I’ve suddenly become more observant of the major holidays, people believe, Almighty God will decide who lives and who dies in the coming year. On the Jewish calendar, it marks the beginning of the year 5785.
Therefore, I wish all of my readers, regardless of religious affiliation, a happy and healthy New Year. Given that the world's three major faiths are all Abrahamic, celebrating the beginning of the new Rosh Hashanah and the creation of the world is a universal message, even if you don't necessarily believe in the biblical creation story.
We received a lot of feedback on our story “Lessons from Grenfell” about the evacuation of people with disabilities. Given climate change, we really don't know where disasters will occur, and it's not even possible to suggest that a person who might have evacuation issues move there because it doesn't exist.
Additionally, we’ve found in forums and one-on-one conversations that many people living with COVID-19 are using expressive arts to document their feelings about the situation. If this is you, or you want to create and share anything from a painting, a poem, a photo to a piece of music to express this feeling, your creativity can help shine a light on those affected by this condition challenges and triumphs faced. For more information, please visit www.longcovidartproject.com
===========================
In the news we cover today, One study suggests low-dose lithium aspartate may help patients with long-acting COVID-19, and another study reports commonalities between patients with long-acting COVID-19-related lung problems and others with pulmonary fibrosis, Utah A report released by the state says one in 12 Utahns are suffering from a long-term COVID outbreak.
COVID-19
A new study suggests that small doses of lithium may help COVID-19 patients. The study, “Lithium aspartate treats long-term COVID-19 fatigue and cognitive impairment: a randomized clinical trial,” found that low doses of lithium aspartate were ineffective in treating symptoms such as fatigue and brain fog. However, subsequent dose-finding studies have provided some evidence that higher doses may be effective.
The study was led by Thomas J. Guttuso, Jr., MD, professor of neurology at the University at Buffalo Jacobs School of Medicine and Biomedical Sciences and a neurologist at UBMD, who said in a statement: “[I]This is a negative study with a positive twist. “
Guttoso said nine of 10 Long Covid patients he treated with 5 to 15 mg of lithium aspartate daily saw “very good results” in improving symptoms of fatigue and brain fog. But this is not the result of a randomized clinical study. However, he then went on to treat a small group of three participants in the original study with doses ranging from 40 to 45 mg, and those patients actually reported a decrease in brain fog and fatigue.
“This is a small number of patients, so these findings can only be considered preliminary,” he said. “Perhaps achieving higher blood lithium levels could improve fatigue and brain fog in long-term COVID-19 patients.”
Northwestern University researchers focus on long-term coronavirus research say one of their findings could provide a potential treatment for thousands of patients who develop lung problems, including persistent coughing, after contracting SARS-CoV-2.
Dr. Mark Sala, a pulmonologist and co-director of Northwestern University's Comprehensive COVID-19 Center, said he and his colleagues found that white blood cells, including neutrophils and monocytes, continued to migrate into the lungs of patients with radiographic abnormalities. The same biological processes that cause other types of lung damage and lead to pulmonary fibrosis appear to be present in the patients in the study, he said.
“Explanations for this commonality may not only aid in the development of future evolving treatments for COVID-19, but also our understanding of lung fibrosis caused by other conditions,” Sala said in a statement announcing the study. change.” “
A new study finds 1 in 12 Utahns at present have LWeng coronavirus. The report was released by the Utah Department of Health and Human Services.
The report gets it right: “It can significantly impact a person's quality of life and well-being. Diagnosis is challenging because there are no simple tests or validated screening tools. Treatment options are limited and do not guarantee resolution of the disease.”
The report includes several artworks created by COVID-19 patients that reflect their feelings about the situation.
Blake Bockholt, a former teacher and distance runner who now uses a wheelchair, attended a news conference announcing the report's findings. He told the Utah News-Dispatch, who was also present, “[I]It's one thing to get hurt, but know that it will get better. It's a whole other story when you don't have the energy to go out. Everyone else is doing what you wish you could do. You are trapped in your body; you are trapped in your mind. It can lead to a mental health crisis. “
USA
A preclinical study shows that a drug-free nasal spray, officially called Pathogen Capturing and Neutralizing Spray (PCANS) protects users from a wide range of airborne viruses. PCANS uses a multi-modal approach to enhance efficacy, covering the nasal cavity, capturing large respiratory droplets in the air and acting as a physical barrier against a broad spectrum of viruses and bacteria while rapidly neutralizing them with over 99.99% efficiency.
Akita Biosciences, the developer of PCANS, recently launched a nasal spray under the Profi brand. The peer-reviewed study, titled “Toward a radically simple multimodal nasal spray for preventing respiratory infections,” was published in the journal Advanced Materials.
This report describes the Pathogen Capture and Neutralizing Spray (PCANS), which utilizes a multimodal approach to enhance efficacy. PCANS coats the nasal cavity and captures large numbers of respiratory droplets in the air, acting as a physical barrier against a wide range of viruses and bacteria while quickly neutralizing them with over 99.99% efficiency.
National respiratory virus season is here, and it’s time to prepare people Get your coronavirus and flu vaccine. Since respiratory virus season tends to peak between December and March, getting vaccinated in October can help provide protection throughout the season.
Owner of a Chicago laboratory company coronavirus Between February 2021 and February 2022, coronavirus tests at multiple testing sites were not performed as required, resulting in claims filed with the U.S. Department of Health and Human Services' Health Resources and Services Administration. Zishan Alvi, the owner of LabElite who caused patients to pay extra to get fast PCR test results, has pleaded guilty to multiple charges. As part of Project Alvey, labs issued negative test results to patients who opted for expedited services, even though the labs either didn't have the actual test samples or the results were inconclusive.
Alvi, whose name means “prince” in Arabic, also transferred funds fraudulently obtained from LabElite accounts to personal accounts and used the funds to purchase cars, invest in stocks and cryptocurrency. He faces 20 years in federal prison.
global
Border closure between Republic of Ireland and Northern Ireland Dr Catherine McDonald, former medical director at Western Health Trust, told CovidInvested that the early years of the pandemic had a significant impact on hospital staff and patients due to Alternaghelvin Hospital's proximity to the Londonderry border. She also told the inquiry that being centrally located in two jurisdictions meant there were different rules and lockdown dates, which had led to a surge in Covid-19 cases in the North West.
The Commission of Inquiry is currently looking into the impact of the pandemic on the UK's four national healthcare systems.
Other healthcare news
Death toll on California dairy farms continues to rise as H5N1 bird flu spreads The speed is much higher than expected. The Los Angeles Times recently reported that dairy operators have been told to expect mortality rates to be less than 2 percent, but preliminary reports indicate that 10 to 15 percent of infected cattle are dying, according to veterinarians and dairy farmers. State health officials also reported two suspected cases of H5N1 among dairy workers in Tulare County, the nation's largest dairy-producing county.
Hurricane Helene floods a factory owned by Baxter International Marion, North Carolina, is one of the largest providers of intravenous fluids in the United States. As a result, some hospitals may receive only 40% of their normal order volume and must ration fluids carefully and reduce elective surgeries in some cases. Baxter said it would spare no effort to get the factory back into production, but said it had “no timetable for when operations will resume.”
The World Health Organization authorizes Abbott Laboratories Last week, the monkeypox, or MPOX, diagnostic test was approved for emergency use, the first time the agency has approved such a test, to bolster testing capabilities in countries facing outbreaks of the disease.
Epidemic Statistics
Global data at a glance
As of September 15, 2024, the total number of global coronavirus cases since the pandemic began was 776,281,230, with an increase of 76,090 in the past seven days, according to data compiled by KFF, a nonpartisan health research organization.
The cumulative death toll was 7,065,880, an increase of 1,500 over the same period and 386 month-on-month.
A look at current U.S. COVID-19 statistics
Data released by the U.S. Centers for Disease Control and Prevention on September 23 showed that the test positivity rate was 11.6% in the week ending September 21, 2024, a decrease of 2.3 percentage points in the latest week. Meanwhile, as of September 28, 2024, the proportion of emergency room visits diagnosed with SARS-CoV-2 was 1.1%, a figure that was down 0.6 percentage points from 1.7% in the previous period.
As of September 14, 2024, the number of hospitalizations due to SARS-CoV-2 in the United States currently stands at 3.7 per 100,000 people, which is down from 4 the previous week.
Meanwhile, as of September 24, the mortality rate due to SARS-CoV-2 was 1.9%, a figure that fell by 0.1 percentage points from the previous week.
Vaccination focus
At press time, about 70.6% of the world's population had received at least one dose of a coronavirus vaccine, according to Our World in Data, an online scientific publication that tracks such information. To date, 13.58 billion vaccine doses have been administered globally, and as of August 12, 2024, the seven-day average daily vaccine doses administered was less than 0.01 doses per million people. Please note that the data provided in our world data has not been updated since this date.
=========================================
Anna Breuer contributed to this issue.
The Long Covid Monitor is a publication of the Long Covid Research Centre. www.longcov.org
If you have COVID-19 and need to talk to someone, call the COVID-19 Peer Advice Line or HOPELINE. HOPELINE is our free, confidential support and information service.
☏ 844 Longkov (844 566-4268)
(Photo: Acura Media Group)
[ad_2]
